ncRNA name
hsa-miR-199a
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Wnt/Ī²-catenin-ABCG2 signaling pathway
Cancer name
Colorectal Cancer
Cancer site
Colon, Rectum, and Anus
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/Ī²-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells.
Tissue resource
primary colorectal cancer samples
primary colorectal cancer samples
Experiment
qRT-PCR
Institute
the First Affiliated Hospital of XinXiang Medical University
Country
China
Continent
Asia